Pvs25-IMX313/Matrix-M1

· University of Oxford

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pvs25-IMX313/Matrix-M1, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine [EARLY_Phase 1]